Related Experiment Video
Updated: May 3, 2026
11:13
A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity
Published on: July 12, 2018
7.9K
[Glypican 3 expression in hepatoblastoma and its diagnostic implication]
Feng-hua Wang1, Jian-ming Wen2, Heong-ting Vong
1Department of Pathology, Guangzhou Women and Children's Medical Center, Guangzhou 510623, China.
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology
|February 11, 2014
Summary
Glypican-3 (GPC3) is highly expressed in fetal epithelial cells of hepatoblastoma, aiding diagnosis. Normal liver cells and other hepatoblastoma subtypes show little to no GPC3 expression.
Area of Science:
- Oncology
- Pathology
- Biochemistry
Context:
- Hepatoblastoma is a rare pediatric liver cancer.
- Accurate diagnosis is crucial for effective treatment.
- Biomarker identification is key in pediatric oncology.
Purpose:
- To investigate the expression of glypican-3 (GPC3) in hepatoblastoma.
- To determine the diagnostic utility of GPC3 in differentiating hepatoblastoma subtypes.
- To assess GPC3 expression in non-neoplastic liver tissue.
Summary:
- Immunohistochemistry revealed GPC3 expression in 100% of fetal epithelial cells within hepatoblastoma.
- Embryonic epithelial cells, undifferentiated small cells, and mesenchymal components showed negative or weak GPC3 expression.
- Adjacent non-neoplastic hepatocytes were negative for GPC3, unlike tumor cells.
Impact:
- GPC3 immunohistochemistry serves as a valuable diagnostic tool for hepatoblastoma in infants and children.
- This finding can improve diagnostic accuracy and potentially guide therapeutic strategies.
- Establishes GPC3 as a specific marker for the fetal component of hepatoblastoma.
